Cargando…
A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care
To improve prognosis in recurrent glioblastoma we developed a treatment protocol based on a combination of drugs not traditionally thought of as cytotoxic chemotherapy agents but that have a robust history of being well-tolerated and are already marketed and used for other non-cancer indications. Fo...
Autores principales: | Kast, Richard E., Boockvar, John A., Brüning, Ansgar, Cappello, Francesco, Chang, Wen-Wei, Cvek, Boris, Dou, Q. Ping, Duenas-Gonzalez, Alfonso, Efferth, Thomas, Focosi, Daniele, Ghaffari, Seyed H., Karpel-Massler, Georg, Ketola, Kirsi, Khoshnevisan, Alireza, Keizman, Daniel, Magné, Nicolas, Marosi, Christine, McDonald, Kerrie, Muñoz, Miguel, Paranjpe, Ameya, Pourgholami, Mohammad H., Sardi, Iacopo, Sella, Avishay, Srivenugopal, Kalkunte S., Tuccori, Marco, Wang, Weiguang, Wirtz, Christian R., Halatsch, Marc-Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720600/ https://www.ncbi.nlm.nih.gov/pubmed/23594434 |
Ejemplares similares
-
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide
por: Kast, Richard E., et al.
Publicado: (2014) -
In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma
por: Halatsch, Marc-Eric, et al.
Publicado: (2021) -
Epidermal to Mesenchymal Transition and Failure of EGFR-Targeted Therapy in Glioblastoma
por: Pala, Andrej, et al.
Publicado: (2012) -
Augmentation of 5-Aminolevulinic Acid Treatment of Glioblastoma by Adding Ciprofloxacin, Deferiprone, 5-Fluorouracil and Febuxostat: The CAALA Regimen
por: Kast, Richard E., et al.
Publicado: (2018) -
Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen
por: Kast, Richard E, et al.
Publicado: (2017)